RxDoctor Payments Data

Jay Rhee

Neurological Surgery · Rockville, MDNPI 1659532489

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Stryker at 58.1% of the total. Reporting peaked in 2023 at $41,257 and has fallen 66.7% since, to $13,754 in 2025.

$97,692in general payments, 2019–2025

Across 184 payments — averaging $530.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$57K
  • Bioventus LLC$29K
  • Alphatec Spine, Inc$9K
  • Globus Medical$737
  • Spineology Inc.$521
  • Painteq LLC$453
  • plus $2K from 14 others
$2,175in research payments, 2019–2025

Across 3 payments — averaging $725.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • QED Therapeutics, Inc.$2K

What the payments were for

  • Consulting fees$47,68849%
  • Speaking & faculty fees$26,32827%
  • Travel & lodging$13,44814%
  • Food & beverage$10,22910%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$97,692 in reported general payments places this provider in the 85th percentile of 133 neurological surgery providers in Maryland.

See all neurological surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$641,657
Medicare patients
633
Services billed
1,517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin68$1,296
Pregabalin28$814
Methocarbamol82$771
Tizanidine Hcl44$699
Methylprednisolone75$529
Oxycodone Hcl101$501
Cyclobenzaprine Hcl25$388
Celecoxib14$384
Meloxicam35$181
Tramadol Hcl44$150
Dexamethasone11$134

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Rockville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →